EHEALTH INC (EHTH) Fundamental Analysis & Valuation

NASDAQ:EHTH • US28238P1093

Current stock price

1.5 USD
0 (0%)
At close:
1.47 USD
-0.03 (-2%)
After Hours:

This EHTH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. EHTH Profitability Analysis

1.1 Basic Checks

  • EHTH had negative earnings in the past year.
  • In the past year EHTH has reported a negative cash flow from operations.
  • EHTH had negative earnings in each of the past 5 years.
  • EHTH had a negative operating cash flow in each of the past 5 years.
EHTH Yearly Net Income VS EBIT VS OCF VS FCFEHTH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M -150M

1.2 Ratios

  • With a Return On Assets value of -0.82%, EHTH is not doing good in the industry: 83.78% of the companies in the same industry are doing better.
  • The Return On Equity of EHTH (-1.07%) is worse than 83.11% of its industry peers.
  • EHTH has a better Return On Invested Capital (3.54%) than 61.49% of its industry peers.
Industry RankSector Rank
ROA -0.82%
ROE -1.07%
ROIC 3.54%
ROA(3y)-3.27%
ROA(5y)-6.25%
ROE(3y)-4.07%
ROE(5y)-7.56%
ROIC(3y)N/A
ROIC(5y)N/A
EHTH Yearly ROA, ROE, ROICEHTH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 -10

1.3 Margins

  • Looking at the Operating Margin, with a value of 12.36%, EHTH is in line with its industry, outperforming 50.68% of the companies in the same industry.
  • In the last couple of years the Operating Margin of EHTH has grown nicely.
  • EHTH does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM 12.36%
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5Y6.22%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EHTH Yearly Profit, Operating, Gross MarginsEHTH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. EHTH Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), EHTH is destroying value.
  • EHTH has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for EHTH has been increased compared to 5 years ago.
  • The debt/assets ratio for EHTH is higher compared to a year ago.
EHTH Yearly Shares OutstandingEHTH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
EHTH Yearly Total Debt VS Total AssetsEHTH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • EHTH has an Altman-Z score of 0.97. This is a bad value and indicates that EHTH is not financially healthy and even has some risk of bankruptcy.
  • EHTH has a better Altman-Z score (0.97) than 79.73% of its industry peers.
  • EHTH has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.12, EHTH is doing good in the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z 0.97
ROIC/WACC0.48
WACC7.39%
EHTH Yearly LT Debt VS Equity VS FCFEHTH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

2.3 Liquidity

  • EHTH has a Current Ratio of 3.37. This indicates that EHTH is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 3.37, EHTH belongs to the best of the industry, outperforming 92.57% of the companies in the same industry.
  • A Quick Ratio of 3.37 indicates that EHTH has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 3.37, EHTH belongs to the top of the industry, outperforming 92.57% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.37
Quick Ratio 3.37
EHTH Yearly Current Assets VS Current LiabilitesEHTH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. EHTH Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 2.86% over the past year.
  • EHTH shows a small growth in Revenue. In the last year, the Revenue has grown by 4.06%.
  • The Revenue has been decreasing by -1.01% on average over the past years.
EPS 1Y (TTM)2.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-24.5%
Revenue 1Y (TTM)4.06%
Revenue growth 3Y10.97%
Revenue growth 5Y-1.01%
Sales Q2Q%3.51%

3.2 Future

  • EHTH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 130.21% yearly.
  • The Revenue is expected to grow by 4.75% on average over the next years.
EPS Next Y656.67%
EPS Next 2Y219.63%
EPS Next 3Y130.21%
EPS Next 5YN/A
Revenue Next Year-22.59%
Revenue Next 2Y-9.59%
Revenue Next 3Y-0.1%
Revenue Next 5Y4.75%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EHTH Yearly Revenue VS EstimatesEHTH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M
EHTH Yearly EPS VS EstimatesEHTH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 -2 4

More info and screens

Find the best growth stocksShow best growing peers

5

4. EHTH Valuation Analysis

4.1 Price/Earnings Ratio

  • EHTH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • With a Price/Forward Earnings ratio of 1.32, the valuation of EHTH can be described as very cheap.
  • 93.92% of the companies in the same industry are more expensive than EHTH, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of EHTH to the average of the S&P500 Index (22.70), we can say EHTH is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 1.32
EHTH Price Earnings VS Forward Price EarningsEHTH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, EHTH is valued cheaper than 97.30% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 0.96
EHTH Per share dataEHTH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • EHTH's earnings are expected to grow with 130.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y219.63%
EPS Next 3Y130.21%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EHTH Dividend Analysis

5.1 Amount

  • EHTH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EHTH Fundamentals: All Metrics, Ratios and Statistics

EHEALTH INC

NASDAQ:EHTH (3/24/2026, 4:30:02 PM)

After market: 1.47 -0.03 (-2%)

1.5

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)02-26
Earnings (Next)05-05
Inst Owners71.01%
Inst Owner Change-4.15%
Ins Owners4.6%
Ins Owner Change8.86%
Market Cap46.60M
Revenue(TTM)554.01M
Net Income(TTM)-10.40M
Analysts50
Price Target7.48 (398.67%)
Short Float %4.39%
Short Ratio1.6
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.77%
Min EPS beat(2)-3.64%
Max EPS beat(2)2.1%
EPS beat(4)3
Avg EPS beat(4)16.25%
Min EPS beat(4)-3.64%
Max EPS beat(4)53.86%
EPS beat(8)4
Avg EPS beat(8)-0.04%
EPS beat(12)6
Avg EPS beat(12)0.22%
EPS beat(16)10
Avg EPS beat(16)9.34%
Revenue beat(2)0
Avg Revenue beat(2)-0.98%
Min Revenue beat(2)-1.5%
Max Revenue beat(2)-0.47%
Revenue beat(4)2
Avg Revenue beat(4)9.74%
Min Revenue beat(4)-1.5%
Max Revenue beat(4)29.61%
Revenue beat(8)5
Avg Revenue beat(8)9.49%
Revenue beat(12)8
Avg Revenue beat(12)10.36%
Revenue beat(16)10
Avg Revenue beat(16)6.46%
PT rev (1m)0%
PT rev (3m)-13.73%
EPS NQ rev (1m)-42.61%
EPS NQ rev (3m)-41.16%
EPS NY rev (1m)181.86%
EPS NY rev (3m)181.86%
Revenue NQ rev (1m)-23.81%
Revenue NQ rev (3m)-23.81%
Revenue NY rev (1m)-21.5%
Revenue NY rev (3m)-22.09%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1.32
P/S 0.08
P/FCF N/A
P/OCF N/A
P/B 0.05
P/tB 0.05
EV/EBITDA 0.96
EPS(TTM)-0.2
EYN/A
EPS(NY)1.14
Fwd EY75.71%
FCF(TTM)-1.31
FCFYN/A
OCF(TTM)-0.82
OCFYN/A
SpS17.83
BVpS31.34
TBVpS31.34
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.82%
ROE -1.07%
ROCE 5.89%
ROIC 3.54%
ROICexc 3.79%
ROICexgc 3.79%
OM 12.36%
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-3.27%
ROA(5y)-6.25%
ROE(3y)-4.07%
ROE(5y)-7.56%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-0.96%
ROICexc growth 3YN/A
ROICexc growth 5Y0.4%
OM growth 3YN/A
OM growth 5Y6.22%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA 1.37
Cap/Depr 111.27%
Cap/Sales 2.76%
Interest Coverage 7.68
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.37
Quick Ratio 3.37
Altman-Z 0.97
F-Score2
WACC7.39%
ROIC/WACC0.48
Cap/Depr(3y)81.36%
Cap/Depr(5y)85.62%
Cap/Sales(3y)2.52%
Cap/Sales(5y)3.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-24.5%
EPS Next Y656.67%
EPS Next 2Y219.63%
EPS Next 3Y130.21%
EPS Next 5YN/A
Revenue 1Y (TTM)4.06%
Revenue growth 3Y10.97%
Revenue growth 5Y-1.01%
Sales Q2Q%3.51%
Revenue Next Year-22.59%
Revenue Next 2Y-9.59%
Revenue Next 3Y-0.1%
Revenue Next 5Y4.75%
EBIT growth 1Y107.28%
EBIT growth 3YN/A
EBIT growth 5Y5.15%
EBIT Next Year-9.54%
EBIT Next 3Y7.95%
EBIT Next 5YN/A
FCF growth 1Y-30.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-38%
OCF growth 3YN/A
OCF growth 5YN/A

EHEALTH INC / EHTH Fundamental Analysis FAQ

What is the ChartMill fundamental rating of EHEALTH INC (EHTH) stock?

ChartMill assigns a fundamental rating of 3 / 10 to EHTH.


What is the valuation status of EHEALTH INC (EHTH) stock?

ChartMill assigns a valuation rating of 5 / 10 to EHEALTH INC (EHTH). This can be considered as Fairly Valued.


What is the profitability of EHTH stock?

EHEALTH INC (EHTH) has a profitability rating of 1 / 10.


Can you provide the financial health for EHTH stock?

The financial health rating of EHEALTH INC (EHTH) is 5 / 10.